Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Complement System01:27

Complement System

9.8K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
9.8K
Neural Regulation01:37

Neural Regulation

43.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.2K
Complementation Tests00:49

Complementation Tests

6.1K
A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
6.1K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Dysregulation of complement at the synapse in P301S mice and human tauopathies.

Acta neuropathologica communications·2026
Same author

Complement in brain and eye disease: shared mechanisms, convergent pathologies, and common therapeutic opportunities.

Mammalian genome : official journal of the International Mammalian Genome Society·2026
Same author

In vivo validation of novel non-invasive PHP.eB AAVs as a potential therapeutic approach for alpha-synucleinopathies.

Acta neuropathologica communications·2025
Same author

The Alzheimer's disease-associated complement receptor 1 variant confers risk by impacting glial phagocytosis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Modeling common Alzheimer's disease with high and low polygenic risk in human iPSC: A large-scale research resource.

Stem cell reports·2025
Same author

CD59, Disulphide-Locked Human C9 and Horse C9 Inhibit Human Membrane Attack Complex Assembly by Similar Mechanisms.

Immunology·2025
Same journal

Non-Alzheimer Aβ deposits in the human CNS: Implications with hypoxia and related conditions.

Brain pathology (Zurich, Switzerland)·2026
Same journal

Distinctly altered TRPC3 and TRPC6 expression patterns in human Alzheimer's disease cortex and hippocampus.

Brain pathology (Zurich, Switzerland)·2026
Same journal

Lewy bodies are surrounded by granulovacuolar degeneration bodies in dementia with Lewy bodies.

Brain pathology (Zurich, Switzerland)·2026
Same journal

A 3-year-old girl with a left optic nerve tumor.

Brain pathology (Zurich, Switzerland)·2026
Same journal

Chromosomal and immune dysregulation underlying granular mitosis in glioblastoma.

Brain pathology (Zurich, Switzerland)·2026
Same journal

Nearest-neighbors assisted unsupervised analysis for methylation array profiling for central nervous system tumors.

Brain pathology (Zurich, Switzerland)·2026
查看所有相关文章

相关实验视频

Updated: Jan 18, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

18.9K

在人类陶病症中补充失调.

Jacqui Nimmo1, Samuel Keat1, Louis De Muynck2

  • 1UK Dementia Research Institute Cardiff, Cardiff University, Cardiff, UK.

Brain pathology (Zurich, Switzerland)
|May 27, 2025
PubMed
概括
此摘要是机器生成的。

补充激活发生在神经元中的人类陶氏病,如皮克病,球状质性陶氏病和皮质根性退行. 这项研究揭示了补充剂在与相关的神经退行和脱髓化中的作用.

关键词:
补充补充补充补充补充补充补充.前性痴呆症前性痴呆症这是一种炎症炎症炎症炎症.骨髓蛋白是什么意思 骨髓蛋白是什么意思知道的 知道的 知道的病症是一种病症.

更多相关视频

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
07:18

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

8.9K
Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
12:55

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

9.4K

相关实验视频

Last Updated: Jan 18, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

18.9K
Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
07:18

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

8.9K
Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
12:55

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

9.4K

科学领域:

  • 神经科学是一个神经科学.
  • 免疫学 免疫学 免疫学
  • 病理学 病理学 病理学

背景情况:

  • 补充系统失调有助于神经退行性疾病,如阿尔茨海默氏症 (AD).
  • 虽然补充剂在粉样蛋白病理学中的作用得到了研究,但其在人类形病变中的参与在很大程度上是未知的.
  • 陶氏病理,独立于粉样蛋白,驱动AD和初级陶氏病变中的神经元损失.

研究的目的:

  • 为了研究人类病亚型的补充激活:皮克病 (PiD),球状质病 (GGT) 和皮质基底退化 (CBD).
  • 为了确定补体激活是否发生在神经元和其他大脑结构在这些病.

主要方法:

  • 免疫组织化学用于评估死后脑组织中的补充成分 (C1q,iC3b,TCC) 来自病病例和对照组.
  • 艾丽莎测量了大脑同质体中的补充蛋白,调节剂和激活产物.
  • 分析了三种病症亚型 (PiD,GGT,CBD).

主要成果:

  • 与对照组相比,所有病亚型的补充激活标志物 (C1q,iC3b,TCC) 在所有病亚型中都较高.
  • 补充沉积 (C1q,C3b/iC3b) 在所有型病变中神经元上突出.
  • 在CBD和GGT中观察到TCC的显著增加.
  • 独特的GGT,C3b/iC3b沉积在髓上表明补充参与脱髓化.
  • 在CBD和GGT中,ELISA证实了CBD和GGT中C3b/iC3b,Ba和I因子的升高.

结论:

  • 在人体病症中,补充在神经元上和邻近神经元上被激活.
  • 这些发现凸显了补体系统在各种病变的发病过程中的作用.
  • 补充可能有助于神经元损伤和脱髓化在特定的病症,如GGT.